Company intelligence / Profile preview

Metronome Therapeutics

Not explicitly stated; likely San Francisco Bay Area based on investor location but unconfirmed., California, United States

Ownership: Private
Development stage: Phase 2

Overview

Metronome Therapeutics develops oncology drugs and has conducted at least one Phase 1 clinical trial investigating the safety and pharmacokinetics of metronomic dosing with orally administered vinorelbine tablets in patients with nonhematologic malignancies lacking standard therapy options. The current status and results beyond this early-stage study are not publicly detailed.

Therapeutic areas: Oncology
Modalities: Small molecules (specifically oral vinorelbine tablets)
Industry: Biotech

Beyond the preview

Go deeper on Metronome Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metronome Therapeutics.

Explore the full profile